Brief
screening test can identify survivors of childhood cancer who would
benefit from mental-health evaluation
A relatively brief screening test
can identify adult survivors of childhood cancer who would benefit
from mental-health evaluation, according to an article in the March
1st issue of the Journal of Clinical Oncology.
"When people who have been treated for
cancer visit their doctor or a survivor clinic, there's a vast amount
of material to cover: their physical health, emotional health, nutrition,
the state of their relationships with their families, their work
life," said lead author, Christopher Recklitis, Ph.D., M.P.H.
"To make the best use of patients' and caregivers' time, we
found it helpful to have an advance idea of which patients are having
emotional difficulties, so their needs can be addressed promptly.
"
In the current study, researchers wanted to
find whether it is practical to administer a screening questionnaire
in a clinical setting and whether the questionnaire is helpful in
identifying cancer survivors who should receive additional mental-health
evaluation.
Investigators gave screening questionnaires
to 101 adult survivors of childhood cancer while they waited for
scheduled appointments: The questionnaire was a customized version
of a standard mental-health screening test. Survivors completed
them while waiting for their appointments.
Almost all of the respondents completed the
questionnaire in less than 30 minutes, and 64 percent indicated
the survey would be "very" or "moderately" helpful
in educating clinicians about their emotional states.
About 30 percent had scores that indicated
distress sufficient to merit further assessment and treatment. Researchers
found that patients whose screening scores indicated one of three
factors--- dissatisfaction with physical appearance, poor physical
health, or history of cranial radiation--- had an increased risk
for significant emotional distress.
"These results will help reach
out to patients who are most likely to be distressed," said
Recklitis. "Although this screening instrument was studied
only in the setting of the Perini Clinic [Dana-Farber Cancer Center],
we hope to develop it for use at other clinics as well."
|